Author： Royce M.E.
Publisher： Adis International
ISSN： 1170-229X
Source： Drugs & Aging, Vol.17, Iss.3, 2000-09, pp. : 201-216
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Disease-Modifying Therapies in Alzheimer's Disease: How Far Have We Come?
By Hüll Michael Berger Mathias
Drugs, Vol. 66, Iss. 16, 2006-01 ,pp. :
Access to resources
Recommend
'Atypical' antipsychotics: how far have we come?
Trends in Pharmacological Sciences, Vol. 22, Iss. 1, 2001-01 ,pp. :
Pharmacogenetics in clinical practice: how far have we come and where are we going?
Pharmacogenomics, Vol. 14, Iss. 7, 2013-05 ,pp. :
From the archives: how much progress have we really made?
Inpharma, Vol. 1, Iss. 1661, 2008-01 ,pp. :
Malaria elimination: how far can we go without a vaccine?
Clinical Medicine, Vol. 11, Iss. 5, 2011-10 ,pp. :